GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) » Definitions » Total Assets

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Total Assets : ฿1,371.7 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Total Assets?

JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets for the quarter that ended in Mar. 2024 was ฿1,371.7 Mil.

During the past 12 months, JSP Pharmaceutical Manufacturing (Thailand) PCL's average Total Assets Growth Rate was 34.10% per year. During the past 3 years, the average Total Assets Growth Rate was 39.60% per year.

During the past 5 years, JSP Pharmaceutical Manufacturing (Thailand) PCL's highest 3-Year average Total Assets Growth Rate was 39.60%. The lowest was 33.70%. And the median was 36.65%.

Total Assets is connected with ROA %. JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized ROA % for the quarter that ended in Mar. 2024 was -0.73%. Total Assets is also linked to Revenue through Asset Turnover. JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover for the quarter that ended in Mar. 2024 was 0.11.

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Assets Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Assets Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
441.91 484.09 1,260.64 1,366.51 1,335.68

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,302.43 1,353.76 1,343.27 1,335.68 1,371.71

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=930.501+405.174
=1,335.7

JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=928.514+443.197
=1,371.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP) Total Assets Explanation

Total Assets is connected with ROA %.

JSP Pharmaceutical Manufacturing (Thailand) PCL's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-9.86/( (1335.675+1371.711)/ 2 )
=-9.86/1353.693
=-0.73 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=155.661/( (1335.675+1371.711)/ 2 )
=155.661/1353.693
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

JSP Pharmaceutical Manufacturing (Thailand) PCL Total Assets Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) » Definitions » Total Assets
Comparable Companies
BKK:DOD BKK:SSF BKK:NV BKK:SFP BKK:JDF BKK:LEE BKK:BIS BKK:TC BKK:SST BKK:CFRESH XSWX:NESN SHSE:603288 KHC GIS XPAR:BN SHSE:600887 SZSE:300999 HRL MKC K
Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
Website
https://www.jsppharma.com
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Headlines

No Headlines